TABLE 2.
Gene set name | Genes n | Direction of change | Two-sided directional | Non-directional | ||
p-value | FDR | p-value | FDR | |||
Blood coagulation | 47 | Up | 4.30 | 3.56 | 11.62 | 11.06 |
Angiogenesis response | 56 | Up | 2.30 | 1.74 | 22.35 | 21.31 |
Hypoxia response | 36 | Up | 1.89 | 1.43 | 7.35 | 6.97 |
Positive regulation of angiogenesis | 35 | Down | 0.98 | 0.79 | 8.38 | 7.94 |
Negative regulation of angiogenesis | 17 | Up | 0.51 | 0.42 | 1.62 | 1.35 |
Fibrosis | 9 | Up | 0.27 | 0.23 | 1.05 | 0.96 |
Regulation of angiogenesis | 11 | Down | 0.08 | 0.08 | 1.12 | 0.96 |
All p-values and false discovery rates (FDRs) reported as −log10 value. Gene sets highlighted in green indicate biological processes identified by gene set enrichment analysis to be differentially upregulated in SARS-CoV-2 infected lungs versus uninfected samples with FDR <0.05.